Kevin Kamolloh
Biographic Data
| ID | 9799989 |
|---|---|
| NAME | Kevin Kamolloh |
| GIVEN NAMES | Kevin |
| FAMILY NAME | Kamolloh |
| SIGNATURE | KAMOLLOH K |
| AFFILIATIONS | Kenya Medical Research Institute |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Implementing long-acting injectable HIV pre-exposure prophylaxis services at private pharmacies in Kenya
INTRODUCTION: Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products will require novel delivery approaches that widen accessibility and prioritise clients' needs and preferences. To understand the potential barriers and facilitators to delivering injectable PrEP via private pharmacies in Kenya, we conducted qualitative formative research. METHODS: From July to September 2023, we interview…
Trajectories of Oral PrEP Adherence Among Young Kenyan Women
Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya
Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya
As countries scale up pre-exposure prophylaxis (PrEP) for HIV prevention, diverse PrEP delivery models are needed to expand access to populations at HIV risk that are unwilling or unable to access clinic-based PrEP care. To identify factors that may influence implementation of retail pharmacy-based PrEP delivery in Kenya, we conducted in-depth interviews with 40 pharmacy clients, 16 pharmacy providers, 16 PrEP clients, and 10 PrEP providers from …
No prominent works on this page.
Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya
As countries scale up pre-exposure prophylaxis (PrEP) for HIV prevention, diverse PrEP delivery models are needed to expand access to populations at HIV risk that are unwilling or unable to access clinic-based PrEP care. To identify factors that may influence implementation of retail pharmacy-based PrEP delivery in Kenya, we conducted in-depth interviews with 40 pharmacy clients, 16 pharmacy providers, 16 PrEP clients, and 10 PrEP providers from …
Trajectories of Oral PrEP Adherence Among Young Kenyan Women
Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya
Implementing long-acting injectable HIV pre-exposure prophylaxis services at private pharmacies in Kenya
INTRODUCTION: Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products will require novel delivery approaches that widen accessibility and prioritise clients' needs and preferences. To understand the potential barriers and facilitators to delivering injectable PrEP via private pharmacies in Kenya, we conducted qualitative formative research. METHODS: From July to September 2023, we interview…
Public health (4 works) · Environmental health (3 works) · Family medicine (3 works) · Health psychology (3 works) · HIV/AIDS Research and Interventions (3 works) · Human immunodeficiency virus (HIV (3 works) · Medicine (3 works) · Nursing (3 works) · Gerontology (2 works) · Global Maternal and Child Health (2 works)